申请人:AbbVie Inc.
公开号:US20130210827A1
公开(公告)日:2013-08-15
The present application relates to calcium channel inhibitors comprising compounds of formula (I), formula (II), formula (III), or formula (IV),
wherein L
1
, R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
and R
c
are as defined in the specification. The present application also relates to compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
本申请涉及到包括公式(I)、公式(II)、公式(III)或公式(IV)化合物的钙通道抑制剂,其中L1、R1、R2、R3、R4、R5、R6、R7和R在说明书中定义。本申请还涉及包括这些化合物的组合物以及使用这些化合物和组合物治疗疾病和疾病的方法。